tranexamic acid has been researched along with 6-ketoprostaglandin f1 alpha in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hunt, R; Perry, S; Pickard, JD; Smythe, PJ; Vile, J; Walker, V | 1 |
1 other study(ies) available for tranexamic acid and 6-ketoprostaglandin f1 alpha
| Article | Year |
|---|---|
Oral nimodipine reduces prostaglandin and thromboxane production by arteries chronically exposed to a periarterial haematoma and the antifibrinolytic agent tranexamic acid.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Carotid Arteries; Cyclohexanecarboxylic Acids; Dinoprost; Dinoprostone; Female; Hematoma; In Vitro Techniques; Male; Nimodipine; Prostaglandins; Prostaglandins E; Prostaglandins F; Rabbits; Thromboxane B2; Tranexamic Acid | 1987 |